Tacrolimus and Spleen disorder - a phase IV clinical study of FDA data

Summary:

Spleen disorder is reported as a side effect among people who take Tacrolimus (tacrolimus), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Methylprednisolone, and have Immunodeficiency disorders.

The phase IV clinical study analyzes which people have Spleen disorder when taking Tacrolimus. It is created by eHealthMe based on reports of 115,828 people who have side effects when taking Tacrolimus from the FDA, and is updated regularly.

What is Tacrolimus?

Tacrolimus has active ingredients of tacrolimus. It is often used in kidney transplant. eHealthMe is studying from 116,161 Tacrolimus users. Check the latest studies of Tacrolimus.

What is Spleen disorder?

Spleen disorder (disease of spleen) is found to be associated with 380 drugs and 410 conditions by eHealthMe. Check the latest studies of Spleen disorder.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

115,828 people reported to have side effects when taking Tacrolimus.
Among them, 13 people (0.01%) have Spleen disorder.

Among these 13 people:

How long have people been on Tacrolimus when they have Spleen disorder? *

What is the gender of people who have Spleen disorder when taking Tacrolimus? *

female: 7.69 %
male: 92.31 %

What is the age of people who have Spleen disorder when taking Tacrolimus? *

What are other drugs people take besides Tacrolimus? *

What are other side effects people have besides Spleen disorder? *

Liver Disorder (liver diseases): 3 people, 23.08%
Malaise (a feeling of general discomfort or uneasiness): 3 people, 23.08%
Post Transplant Lymphoproliferative Disorder: 3 people, 23.08%
Abdominal Pain: 2 people, 15.38%
Retroperitoneal Mass (mass between peritoneum and the posterior abdominal wall): 2 people, 15.38%
Hepatic Mass: 2 people, 15.38%
Weight Decreased: 2 people, 15.38%
Headache (pain in head): 2 people, 15.38%
Lymph Follicular Hypertrophy (an increase in the size of the lymph node follicles): 2 people, 15.38%
Night Sweats (sweating in night): 2 people, 15.38%

What are the existing conditions these people have? *

White Blood Cell Count Decreased: 2 people, 15.38%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 2 people, 15.38%
Klebsiella Infection: 2 people, 15.38%
Immunodeficiency Disorders: 2 people, 15.38%
Burkitt's Lymphoma (cancer of the lymphatic system): 1 person, 7.69%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Tacrolimus and have Spleen disorder?

- Check whether Spleen disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Tacrolimus:

Tacrolimus (116,161 reports)

Spleen disorder treatments and more:

Spleen disorder (2,370 reports)

Browse all side effects of Tacrolimus:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Spleen disorder:

Spleen disorder (380 drugs)

Browse all the conditions that are associated with Spleen disorder:

Spleen disorder (410 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tacrolimus (the active ingredients of Tacrolimus) and Tacrolimus (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.